677 related articles for article (PubMed ID: 10629659)
1. Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions.
Alexandrakis MG; Coulocheri SA; Bouros D; Eliopoulos GD
Anticancer Res; 1999; 19(4C):3607-12. PubMed ID: 10629659
[TBL] [Abstract][Full Text] [Related]
2. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
3. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
4. Use of acute phase proteins in pleural effusion discrimination.
Calikoğlu M; Sezer C; Unlü A; Kanik A; Tamer L; Calikoğlu I
Tuberk Toraks; 2004; 52(2):122-9. PubMed ID: 15241695
[TBL] [Abstract][Full Text] [Related]
5. [Differential diagnosis between exudate and transudate in pleural effusion].
Vázquez F; Michelángelo H; Trevisani H; González F; de Quiros B
Medicina (B Aires); 1996; 56(3):223-30. PubMed ID: 9035477
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions.
Xirouchaki N; Tzanakis N; Bouros D; Kyriakou D; Karkavitsas N; Alexandrakis M; Siafakas NM
Chest; 2002 Mar; 121(3):815-20. PubMed ID: 11888965
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
Chung CL; Chen CH; Sheu JR; Chen YC; Chang SC
Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
[TBL] [Abstract][Full Text] [Related]
8. Interleukin -1beta (IL-1 beta), interleukin 6 (IL-6) and tumor necrosis factor (TNF) in plasma and pleural fluid of pneumonia, lung cancer and tuberculous pleuritis.
Ilonidis G; Parapanisiou E; Anogeianaki A; Giavazis I; Theofilogiannakos EK; Tsekoura P; Kidonopoulou K; Trakatelli C; Polimenidis Z; Conti P; Anogianakis G
J Biol Regul Homeost Agents; 2006; 20(1-2):41-6. PubMed ID: 18088554
[TBL] [Abstract][Full Text] [Related]
9. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
Castaño Vidriales JL; Amores Antequera C
Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of adenosine deaminase to differentiate exudates and transudates.
Jadhav AA; Bardapurkar JS
Indian J Physiol Pharmacol; 2007; 51(2):170-4. PubMed ID: 18175662
[TBL] [Abstract][Full Text] [Related]
11. Cytokine profile in pleural fluid and serum after lung transplantation.
Teixeira RH; Antonangelo L; Vargas FS; Caramori ML; Afonso JE; Acencio MM; Pego-Fernandes PM; Jatene FB
Transplant Proc; 2010 Mar; 42(2):531-4. PubMed ID: 20304185
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of cytokine measurement in pleural effusion].
Naito T; Ohtsuka M; Ishikawa H; Satoh H; Hasegawa S
Kekkaku; 1997 Oct; 72(10):565-72. PubMed ID: 9386355
[TBL] [Abstract][Full Text] [Related]
13. Pleural fluid and serum soluble interleukin-2 receptors in pleural effusions.
Sarandakou A; Poulakis N; Rizos D; Phocas I
Anticancer Res; 1991; 11(3):1365-8. PubMed ID: 1888173
[TBL] [Abstract][Full Text] [Related]
14. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
Zhou J; Zhao Q; Yao H
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
[TBL] [Abstract][Full Text] [Related]
15. Expression of soluble triggering receptor expression on myeloid cells-1 in pleural effusion.
Huang LY; Shi HZ; Liang QL; Wu YB; Qin XJ; Chen YQ
Chin Med J (Engl); 2008 Sep; 121(17):1656-61. PubMed ID: 19024094
[TBL] [Abstract][Full Text] [Related]
16. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
Kojiro N; Moriwaki Y; Ito M; Nishiki M; Shirasaka T; Kokubu T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):100-4. PubMed ID: 2355670
[TBL] [Abstract][Full Text] [Related]
17. [Pleural fluid to serum cholinesterase ratio to discriminate between transudates and exudates: reevaluation in 177 patients].
García Pachón E; Padilla Navas I; Molina Siles M; López-Azorín F
Rev Clin Esp; 1998 Mar; 198(3):129-32. PubMed ID: 9586433
[TBL] [Abstract][Full Text] [Related]
18. [Interleukin-6 and tumor necrosis factor-alpha in middle ear effusions].
Xie M; Zhou L; Jin X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct; 32(5):280-2. PubMed ID: 10743092
[TBL] [Abstract][Full Text] [Related]
19. The distinction between transudates and exudates.
Gonlugur U; Gonlugur TE
J Biomed Sci; 2005 Dec; 12(6):985-90. PubMed ID: 16228298
[TBL] [Abstract][Full Text] [Related]
20. [Role of c-c chemokines in the determination of pleural effusion etiology].
Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
